Torbjørn Omland

Directeur/Bestuurslid bij CardiNor AS

Health Technology

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Olav Steinnes	M	67	CardiNor AS CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.	-
Ronny Hermansen	M	62	CardiNor AS CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.	-
Dag Christian Christiansen	M	70	CardiNor AS CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.	-
Bjørn Fuglaas	M	65	CardiNor AS CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.	-
Svein W. F. Lien	M	-	CardiNor AS CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.	3 jaar
Frank Frantzen	M	67	CardiNor AS CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway.	-